In addition, we verified in vivo that BST2 overexpression could promote the tumor-forming ability of CFP1-deleted ovarian cancer cells using nude mouse tumor-forming experiments (Fig. 6J). This evidence concerns the gene BST2 and ovarian carcinoma.